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ABSTRACT 
Bacterial persistence is an endogenous survival mechanism employed by bacteria to 
persevere in hazardous environments. In the persister state cells are not inherently resistant 
to the hazardous environmental effects (for example antibiotics), but due to their 
phenotypical attributes their tolerance against the stress factors is heightened. 
Understanding the pathways that govern the processes of bacterial persistence could lead to 
novel antibiotic targets. Toxin-antitoxin systems are mechanisms that (amongst others) 
enable bacterial cells to enter the persister state. The Phd/Doc toxin-antitoxin system is a 
representative of a distinct family of toxin-antitoxin modules found in bacteria.  
The aim of the work was to determine the DNA specificity and biophysical properties of 
Phd, the antitoxin from the Phd/Doc toxin-antitoxin module, using isothermal titration 
calorimetry and an assortment of other methods. 
The first steps in the project were the purification of Phd from an E. coli cell lysate using 
an on-column unfolding/refolding procedure. Next, the suitability of the purified Phd was 
assessed using circular dichroism spectroscopy, and the effect of buffer composition on the 
thermal stability of the protein was assessed with a thermal stability assay. The specificity 
of Phd for its DNA operator was measured using isothermal titration calorimetry. The 8 
base pair palindromic sequence was mutated to help determine which bases affect the 
specificity the most. 
The secondary structure of the isolated protein was found to be in accordance with a 
published reference crystal structure. Determining the thermal stability of Phd in buffers of 
varying composition was inconclusive, as the intrinsically disordered nature of the N-
terminal protein domain interferes with the dye used in the stability assay.  
The data obtained by isothermal titration calorimetry enabled a limited glimpse into the 
operator specificity of Phd. All of the investigated mutants have significantly worse 
binding properties as the wild type oligonucleotide.  
 
Key words: proteins, toxin-antitoxin, isothermal titration calorimetry, 
thermodynamics, DNA interactions 
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EXTENDED ABSTRACT IN SLOVENE 
Bakterijske okužbe s sevi, odpornimi proti širokospektralnim protimikrobnim 
učinkovinam, so vse bolj pogoste in predstavljajo vedno večjo nevarnost za bolnike po 
celem svetu. A bakterije se pred protimikrobnimi učinkovinami ne branijo zgolj z 
rezistenco proti le-tem, temveč tudi s procesom, imenovanim persistenca. Bakterijska 
persistenca je pojav, pri katerem se celicam spremenijo morfološke lastnosti in vstopijo v 
fazo mirovanja. S tem močno povečajo svojo odpornost proti zunanjim stresnim 
dejavnikom (kot so protimikrobne učinkovine, povišana ionska jakost, pomanjkanje hranil, 
UV sevanje), saj le-ti ne morejo vstopiti v celico. Po odstranitvi stresnega dejavnika (na 
primer po koncu terapije s protimikrobnimi učinkovinami) persistentne celice ponovno 
aktivirajo svoj metabolizem in se začnejo razmnoževati. To vodi v ponavljajoče se okužbe 
z bakterijami, ki se na videz vedno odzovejo na terapijo z protimikrobnimi učinkovinami. 
Bakterijski sistemi toksin-antitoksin so ena izmed metabolnih poti, ki v bakterijski celici 
sprožijo persisterski odziv. Obstaja mnogo različnih vrst sistemov toksin-antitoksin, vendar 
je za vse značilno, da je molekula antitoksina manj stabilna od molekule toksina. Predmet 
te magistrske naloge je protein Phd, del sistema toksin-antitoksin Phd /Doc, ki se nahaja na 
bakteriofagu P1 v bakterijah E. coli. Funkcija tega sistema toksin-antitoksin je ohranitev 
bakteriofaga P1 v bakterijski celici, bližnji homolog pa ima pomembno vlogo pri nastanku 
persisterskih celic v bakterijah rodu Salmonella. Phd je relativno majhen protein z 
molekulsko maso 8.1 kDa in je sestavljen iz dveh domen. N-končna domena je ključna za 
dimerizacijo proteina Phd in vezavo le-tega na zaporedje operona phd/doc, C-končna 
domena pa je zadolžena za vezavo s toksinom Doc. Dva strukurna elementa, ki sta 
ključnega pomena za delovanje antitoksina Phd, sta regija »glave«, ki prepozna 
palindromsko zaporedje operatorja, in »rep« proteina, ki je intrinzično neurejen in preko 
steričnega oviranja preprečuje popolno zaviranje operona. 
Cilj našega dela je bil odkriti vpliv mutacij v palindromnem zaporedju operatorja na 
vezavne lastnosti z antitoksinom Phd. Hkrati pa smo proučevali tudi vpliv ionske jakosti na 
sekundarno strukturo proteina ter na njegovo termično stabilnost. 
Za pridobitev čistega proteina Phd smo izvedli čiščenje z uporabo afinitetne 
kromatografije. Pri tem smo celični lizat bakterij E. coli, v katerem sta se nahajala Phd in 
Doc v obliki kompleksa, nanesli na kolono (GE Healthcare 5 ml HisTrap™HP). Nato smo 
izvedli korak denaturacije proteinov na koloni, s čimer smo razbili proteinski kompleks ter 
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tako ločili antitoksin Phd od toksina Doc. Izolirane frakcije proteina Phd smo nato združili 
ter dodatno prečistili in skoncentrirali z metodo gelske filtracije. 
Naslednji korak je bil analiza sekundarne strukture proteina v pufrih različne ionske jakosti 
z metodo CD spektroskopije. S temi meritvami smo potrdili ustreznost izoliranega Phd, ter 
hkrati preučili hipotezo, da v pufru višje ionske jakosti intrinzično neurejeni rep proteina 
privzame bolj strukturirano obliko. Krivulje CD-spektra so pri vseh treh uporabljenih 
pufrih kazale obliko, značilno za proteine, ki so pretežno sestavljeni iz α-vijačnic, kar je 
bilo v skladu z našimi pričakovanji, osnovanimi na poznavanju sekundarne strukture 
proteina Phd. Naše meritve pa niso potrdile hipoteze, da višja vsebnost ionov v pufru vodi 
v manj neurejen protein. Meritve, pridobljene v različnih pufrih, so se bistveno razlikovale 
le v jakosti izmerjenega signala. Možen razlog za to je izbira iona, s katerim smo povečali 
ionsko jakost pufra. Za to smo uporabili NaCl, ki disociira na ione Cl- in Na+. Prav za 
kloridne ione pa je značilno, da v območju UV-spektra v bližini 200 nm intenzivno 
absorbirajo svetlobo. 
Da bi zagotovili optimalne pogoje pri izvedbi izotermalne titracijske kalorimetrije, smo 
poskusili določiti pufer, v katerem je protein Phd najbolj termično stabilen. V ta namen 
smo izvedli test toplotne stabilnosti (thermal stability assay), pri katerem smo preučili 96 
pufrov različnih vrednosti pH ter ionske jakosti. Metoda, ki smo jo uporabili, temelji na 
barvilu SYPRO orange, ki ob vezavi na hidrofobne regije proteina začne oddajati 
fluorescenčno svetlobo, kar lahko zaznamo z opremo za izvajanje PCR (v našem primeru 
je bil to CFX96 RealTime PCR System). S postopnim višanjem temperature raztopine, v 
kateri je vzorec z barvilom, povzročimo denaturacijo proteina in izpostavitev hidrofobnih 
regij barvilu, ki se nahaja v raztopini. Čeprav se je sestava pufrov precej razlikovala, nismo 
uspeli določiti pufra, ki bi znatno izboljšal termično stabilnost preiskovanega proteina. 
Temperatura tališča proteina je bila v najboljšem pufru namreč le za 1 °C nad povprečjem 
vseh izmerjenih pufrov. Možna razlaga za ta rezultat je način delovanja te metode, saj se 
barvilo SYPRO orange verjetno veže na C-končni intrinzično neurejeni rep Phd še preden 
le-ta zaradi povišane temperatue denaturira. 
Vpliv mutacij v zaporedju DNA, na katerega se veže Phd, smo analizirali z uporabo 
izotermalne titracijske kalorimetrije. S to metodo smo določili termodinamske lastnosti 
vezavne interakcije med proteinom in molekulo DNA. Enoverižne sintezne 
oligonukleotide z določenimi točkovnimi mutacijami smo dimerizirali in jih dializirali 
proti istemu pufru kot vzorce Phd. Ker pri analizah s CD-spektroskopijo in testom toplotne 
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stabilnosti nismo uspeli določiti pufra, ki bi bistveno izboljšal stabilnost Phd, smo pri 
meritvah uporabili 100 mM NaH2PO4 s 100 mM NaCl in pH 7.5. Meritve smo izvajali pri 
temperaturi 298.15 K z napravo MicroCal iTC 200. Pri meritvah smo uporabili 300 µL 
raztopine oligonukleotidov s koncentracijo 20 µM. V to raztopino smo injicirali vzorec 
Phd s koncentracijo 308 µM, volumen posameznega injiciranja je bil 2 µL.  
Z meritvami, pridobljenimi z izotermalno titracijsko kalorimetrijo, smo ugotovili, da 
vsakršne mutacije v oligonukleotidnem zaporedju negativno vplivajo na vezavo Phd. S 
pomočjo spletne podatkovne baze Protein data bank smo pridobljene rezultate ovrednotili 
v povezavi z že znano kristalno strukturo proteina Phd v kompleksu z operatorjem. 
 
Ključne besede: proteini, toksin-antitoksin, izotermalna titracijska kalorimetrija, 
termodinamika, interakcije z DNA 
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1. INTRODUCTION 
 
1.1 Antibiotic resistance 
With the discovery of antibiotics many people believed that humanity had successfully 
thwarted bacterial infections and the resulting medical complications. But soon after the 
widespread start of antibiotic use, bacteria started evolving and developing resistance to 
the different antibiotic types that were in use. In the early years, failed treatment with one 
type of antibiotics was not problematic since there were many other classes with different 
cellular targets available. The real problems began surfacing when microbes started 
developing resistance to multiple different antibiotic types (1). 
This came to be with the advent of broad-spectrum agents. At first, they were exceptionally 
effective, but with that came an increased selective pressure for the microbes to adapt. The 
increase in selective pressure coupled with a fast decline in the introduction of novel 
antibiotics resulted in a number of resistant organisms which cannot be stopped with 
conventional treatments. Among Gram-positive microbes these include glycopeptide-
intermediate sensitivity Staphylococcus aureus, methicillin-resistant Staphylococcus 
aureus, vancomycin-resistant Enterococcus species and penicillin-resistant Streptococcus 
pneumoniae (1). 
Resistance to antibiotics can be active (i.e. an enzyme that degrades the antibiotic) or 
passive (i.e. the outer membrane of Gram-negative bacteria) (2). 
Bacteria can achieve resistance through various methods. They can acquire foreign DNA 
through horizontal gene transfer, transposons and conjugative plasmids, by recombination 
of DNA into their chromosome or by mutations in different chromosome loci (1). 
 
1.2 Persistence, not resistance 
Resistance to antibiotics is not the only mechanism that bacteria employ to survive. 
Another reason for treatment failure that has been discovered a long time ago, yet is only 
now getting more attention, is called bacterial persistence. Persistence is an endogenous 
survival mechanism that microbes employ to endure in hazardous environments. The cells 
that enter the persister state are not inherently resistant to the effects of antibiotics, but due 
to their phenotypical attributes they exhibit a high tolerance to antibiotics (3). 
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The hallmark of the persister state is that at any given time, a small fraction of all the cells 
in a bacterial population spontaneously enters a form of hibernation in which all cell 
processes are slowed down, or virtually stopped. This enables them to weather through 
periods of low nutrient availability, or high toxin concentrations (e.g. antibiotics) in their 
environment. Bacteria can survive in the persister state for prolonged periods of time. Once 
their environment exhibits favourable conditions the persister cells revert back to the active 
form and start growing and dividing. It is also possible for the cells to leave the persister 
state while the environment is still unfavourable, thus causing death of the cell (3). 
 
 
When persister cells are present in a population of bacteria, they can be detected through 
the presence of the »biphasic killing« phenomenon when a lethal dose of a bactericidal 
agent is added to the growth media (Figure 1).  
Upon exposure to a bactericidal agent a fast drop in bacterial counts can be observed. This 
represents the killing of the majority of the population. But this first phase is followed by a 
Figure 1: Biphasic killing phenomenon. »Normal« bacterial cells are shown in dark blue, while 
persister cells are shown in red. Light blue cells are »normal« cells that died due to antibiotic exposure 
(adapted from (4)). 
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second one, which exhibits a far slower rate of killing. This is due to the presence of 
persister cells that are not affected by the bactericidal agent present in the media (4). 
The occurrence of perister cells in wild-type planktonic E. coli populations that are not 
under environmental stress is 1 in a million cells. In stationary cultures, or biofilms that are 
composed of multiple bacterial species that exhibit high antimicrobial resistance, the 
number of persister cells increases dramatically, up to 1 in 100 cells (5). 
Since persister cells survive treatment with antibiotics, they cause frequent relapses of 
bacterial infections in patients. As the bacterial population infecting a patient is not 
resistant to the antibiotic, an improvement is initially observed in the patients’ state of 
health. But upon treatment termination persister cells re-establish the bacterial population, 
thus resulting in a relapse. Through persistance, bacterial infections can survive prolonged 
and aggressive antibiotic treatments and ultimately lead to chronic cases of infections (4). 
 
1.2.1 Treating chronic bacterial infections 
Most often the response of medical professionals to recurring infections is with cyclic 
administrations of high doses of antibiotics in hopes of eradicating the infecting bacteria. 
But this method is linked to greatly increased persister levels in isolated colonies. It has 
also been shown in vitro that this results in high selective pressure for mutants that exhibit 
increased rates of persister cells formation (6). 
Conlon et al. (7) found a novel way of potential treatment to cure chronic infections 
facilitated by persister cells. They found that acyldepsipeptide (ADEP)-related compounds 
produced by Streptomyces hawaiensis reliably act against persister cells. ADEP binds to 
the ClpP protease, turning it into a nonspecific protease and initiating degradation of 
various intracellular proteins. It also enables ClpP to function without ATP, thus making it 
possible to act in dormant cells, such as persisters.  
Conlon et al. (7) discovered that upon introduction of ADEP4, an ADEP derivative 
compound, into stable colonies of S. aureus the cell count decreased by 4 orders of 
magnitude in a matter of two days. The same cultures exhibited high tolerance towards 
treatment with a combination of vancomycin, rifampicin and ciprofloxacin. But after day 
three of treatment with ADEP4, the culture population rebounded and achieved its 
previous population. This is due to fast emergence of null clpP (the gene encoding ClpP) 
mutants which are devoid of the ClpP protease. 
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To suppress the mutants, a combination treatment was employed, where ADEP4 and 
rifampicin were used. The combination of these two compounds eradicated the S. aureus 
population to the limit of detection. This shows that mutants lacking the ClpP protease lose 
their ability to survive treatment with antibiotics. The efficacy of the treatment was 
confirmed in vivo. A deep-seated mouse thigh infection model was used which emulates 
deep-seated chronic infections in immunocompromised humans. It is typical for these 
types of infections that bacterial biofilms, which are highly resistant to conventional 
antibiotic treatments, are formed inside the tissue (7). 
As a control experiment a combination of vancomycin and rifampicin was used, but the 
infection was only suppressed and soon rebounded after the administration of antibiotics 
stopped. It was observed that after starting treatment with a combination of ADEP4 and 
rifampicin, the infection abated, and the tissue was bacteria-free within 24 hours (7).  
In conclusion, there is a lot of potential for the development of novel antibiotics targeting 
the intracellular pathways leading to persister formation. 
 
1.3 Toxin-antitoxin systems 
Toxin-antitoxin (TA) systems are mechanisms that (amongst others) enable bacterial cells 
to enter the persister state (8). The first gene loci encoding a TA system were discovered 
over thirty years ago (9). It was discovered that they play an important role in the 
maintenance of plasmids inside a bacterial cell (10). A TA system is composed of two 
components, the toxin which is a relatively stable (long lived) protein that prevents the 
transcription of DNA, and the antitoxin, which is much shorter-lived protein or RNA 
molecule and is quickly degraded in the cell. Upon losing the plasmid encoding these two 
molecules, the cell degrades the labile antitoxin and is left only with the more stable toxin 
which results in cell death (11). This phenomenon came to be known as post segregational 
killing (PSK) (10). 
Since the discovery of the first TA system, thousands of different TA operons have been 
identified. They are found on plasmids (12), in phages (11) but mostly on chromosomes of 
many free-living bacteria, where they enable bacteria to enter the persister state in response 
to environmental stress (13). 
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1.3.1 Classification of TA systems 
In all TA systems the toxin is a protein, whereas the antitoxin can be both a low-molecular-
weight protein or a noncoding RNA (5). Thus, the classification of TA systems is based on 
the molecular characteristics and mechanism of action of the antitoxin (4).  
Presently there are six different known classes of TA system types (5) as summarized in 
Figure 2. In connection to persister formation only type I and type II TA systems have 
been extensively studied (4). Type I toxins are mostly small proteins that prevent the 
synthesis of ATP through the formation of pores in the cellular membrane, which halts the 
proton-motive force (14). Their antitoxins are antisense RNA molecules which silence the 
expression of toxin molecules by binding their respective mRNA counterparts (15).  
In type II TA systems, toxins and antitoxins are both small cytoplasmic proteins. The 
toxins act by repressing crucial cellular processes such as replication or translation of 
DNA. The half-life of the antitoxin is very short compared to the one of the toxin since it is 
being actively degraded by intracellular proteases. Therefore, it needs to be constantly 
replenished. The antitoxin acts by forming a tight noncovalent complex with the toxin, 
thereby preventing it from acting on its targets (16). 
The antitoxins of the type III systems are small RNA molecules, as in type I systems. The 
difference is that instead of binding to toxin mRNA, the type III antitoxin forms 
pseudoknots that bind directly to the toxin molecules (17).  
In type IV systems, toxin and antitoxin are both proteins as in type II TA systems. But the 
difference is that the toxins and antitoxins in type IV systems never actually interact. 
Rather, they exert opposing interactions on a common target. In the TA systems described 
as type IV, the toxin acts by inhibiting the polymerization of the bacterial cytoskeletal 
proteins because of which cell division is halted. The antitoxin on the other hand promotes 
and stabilizes the cytoskeleton formation and thus counteracts the toxin (18). However, by 
this definition of TA system, also restriction endonuclease/ pairs and many other opposing 
enzymatic pairs such as kinase/phosphatase could be described as TA modules, making 
this class extremely broad. 
In the type V system, the antitoxin is a RNase that degrades the toxin mRNA, whereas the 
toxin is a small protein molecule. When the cell is under stress, a type II toxin degrades the 
type V antitoxin which enables the type V toxin mRNA to be translated. The toxin then 
acts similar to the type I toxins, by creating pores in the cell membrane (19).  
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Figure 2: The six different classes of toxin-antitoxin systems. The various antitoxin operons and proteins 
are shown in light blue, while the toxin operons and proteins are shown in orange (adapted from (5)). 
 
The most recently discovered TA system is categorized as type VI. Both the toxin and 
antitoxin are proteins. The toxin acts by preventing elongation during the replication of 
DNA by outcompeting the other clamp-binding proteins. The antitoxin promotes the 
toxins' degradation by acting as a proteolytic adaptor to the ClpXP protease protein (20). 
 
1.4 The Phd/Doc toxin-antitoxin system 
The Phd/Doc TA system was found on the bacteriophage P1 plasmid present in E. coli. 
Lehner et al. (11) observed that cells containing the P1 plasmid grew normally, while cells 
that lost the plasmid died. The molecules that cause this phenomenon were named after 
their observed function. The molecule that causes death of the host cell upon loss of the 
plasmid was named "death on curing" (from here on referred to as Doc) and represents the 
toxin in this TA system. The molecule that enables the host cell with the plasmid to survive 
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was named "prevents host death" (from here on referred to as Phd) and represents the 
antitoxin in this TA system. 
This TA system belongs to the type II systems and is a representative of a distinct family 
of TA modules found in bacteria. As is typical for type II TA systems, both the toxin and 
antitoxin are proteins. Their structure is shown in Figure 3 below. While the P1-encoded 
phd/doc system functions to retain P1 in its plasmidic form in an E. coli population, a close 
homologue in Salmonella is instrumental for the formation of persister (21). 
 
Figure 3: A: Structure of Phd2. Phd monomer chains are shown in red and orange, while loops are 
shown in white. The dashed lines on the C-terminus of Phd represent the intrinsically disordered random 
coil (PDB ID: 3HRY). B: Structure of Doc. Secondary structure elements are shown in blue, while loops 
are shown in white (PDB ID: 3K33). 
 
The toxin Doc from bacteriophage P1 (the only family member for which the biochemical 
activity has been investigated) acts by phosphorylating the E. coli translation elongation 
factor EF-Tu, a protein that is crucial for translation elongation (22). Phosphorylated EF-
Tu loses its ability to bind aminoacylated tRNA molecules, thus preventing the synthesis of 
new polypeptides by the ribosome (23).  
The antitoxin Phd is composed of two distinct domains. The N-terminal domain facilitates 
the dimerization of Phd and mediates binding to the DNA operator site of the phd/doc 
operon, while the C-terminal domain interacts with the toxin Doc (24). When not bound to 
Doc, the C-terminal domain of Phd is intrinsically disordered, which makes the protein a 
prime target for intracellular proteases. When binding to Doc, the intrinsically disordered 
region (IDR) of Phd folds into an α-helix which complements the partial FIC 
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(filamentation induced by cyclic AMP) fold of Doc (25) and also prevents Doc from 
binding to and modifying EF-Tu (22). 
 
1.4.1 Structural properties and mechanism of action of Doc 
The toxin Doc is a member of a subfamily of the FIC proteins (25). The FIC family of 
protein domains is present in all life domains and is essential in many intracellular 
processes such as bacterial pathogenesis, or key signalling events in eukaryotes (26). FIC 
domains typically catalyse the adenylylation of target proteins, although several variations 
on this activity exists (for a review of this see (27)).  
Doc consists of an incomplete FIC domain that is complemented by the C-terminal IDR of 
Phd as shown in Figure 4 (25). Prophage P1 Doc consists of 126 amino acids and has a 
molecular weight of 13.6 kDa. Its tertiary structure is made up of six α-helices. It is best 
described as a stack of three helix-loop-helix consecutive motives. The helices α3 and α4 
form the central part of the protein and contain a high number of aliphatic side chains that 
constrain helices α1 and α2 on one side and helices α5 and α6 on the other. The loop 
between the central two helices (α3 and α4) carries a highly conserved motif 
HXFX(D/E)(A/G)N(K/G)R shown in Figure 4. It is present in all members of the Doc 
family of proteins, and mutations within this sequence abolish its activity and toxicity. The 
C-terminal domain of Phd binds into a groove on the Doc molecule. The base of it is 
formed by the helix α4 and its flanks formed by the α1 helix and the before mentioned loop 
that contains the highly conserved sequence, as shown in Figure 4 (25). 
 
In contrast to the classic FIC domains that transfer an AMP moiety to their target, Doc 
transfers a phosphate moiety to the conserved threonine (Thr382) of the translation 
elongation factor EF-Tu. EF-Tu facilitates the binding of aminoacylated tRNA onto 
ribosomes and is thus a crucial component for translation elongation (28). Phosphorylation 
of EF-Tu prevents interaction with tRNA, resulting in a halt of translation elongation. This 
is the likely reason why cells expressing Doc stop dividing and are apparently in a dormant 
state. 
For the cell to recover from the imposed dormancy, the EF-Tu factor needs to be 
dephosphorylated. But the antitoxin Phd does not exhibit the ability to catalyse this 
process. It can only prevent Doc from phosphorylating fresh EF-Tu, not reverse its actions. 
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So, for the cell to exit dormancy, a dedicated but still unidentified phosphatase has to 
recover the EF-Tu factor (22). 
 
 
Figure 4: A structural representation of Doc in complex with a Phd α-helix residue. The Doc α-helices 
are shown in blue and are labelled, while the Phd α-helix residue is shown in yellow. The loops are 
shown in grey. The loop containing the conserved Doc motif HXFX(D/E)(A/G)N(K/G)R is coloured 
red, with its sidechains shown as sticks (adapted from (25)). 
 
1.4.2 Structural properties and mechanism of action of Phd 
The antitoxin Phd is a small protein (8.1 kDa) (29), that is composed of two distinct 
domains, the N-terminal and the C-terminal one. The C-terminal domains function is the 
interaction with the toxin Doc, while the N-terminal domain facilitates the dimerization of 
Phd and the binding to the DNA operator site of the phd/doc operon (24, 25, 29). 
Structurally, the N-terminal domain is composed of a series of α-helices and β-strands. The 
organization of the motifs is βααββα, which form a »head-and-tail« shape which is shown 
in Figure 5. The first two α helices, α1 and α2, form the top of the »head« of the protein, 
while the third helix, α3, extends towards the IDR and forms a secondary hydrophobic 
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core. At the dimerization interface, Phd is composed of a six stranded β-sheet that connects 
the »head« and »tail« sections. Adjacent to it is also a β-hairpin wing. 
 
Figure 5: 3D model of a Phd dimer. One monomer is shown in orange, while the second one is shown in 
red. The structural elements of one monomer are labelled with orange text (adapted from (24)). 
 
The structural elements of the »head« region that contribute to the DNA interaction are the 
β-strand β1, the α-helices α1 and α2. The β-hairpin wing shown in Figure 5 also contributes 
to the binding, since it provides an additional minor-groove contact. The function of β-
strand β1 and α-helix α2 is to support and provide a scaffold for the α-helix α1 which 
connects to the major groove of the DNA molecule. The axis of α1 is almost parallel to the 
DNA axis, so that it serves as a recognition α-helix. The sequence of the Phd binding site 
Oln1 is GTGTACAC. The amino acid residues Phe6, Arg7, Arg10 and Gly11 of the α1 
helix recognize the GTGT sequence and form an electropositive patch with an apolar 
girdle that protrudes into the major groove of the DNA molecule. The Phe6 and Gly11 
amino acid residues form van der Waals bonds with the methyl groups of thymines T7 and 
T8. The Arg7 and Arg10 residues on the other hand form hydrogen bonds with guanines 
G5 and G7 (see Figure 6). Other nucleotides in the GTGTACAC sequence interact with 
the antitoxin through the phosphate backbone of the DNA molecule (24). 
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Figure 6: Phd-DNA binding interaction representation. A) Binding of Phd2 to Oln1. Secondary structure 
elements of both Phd monomers that are essential to the binding are shown as sticks. B) Schematic of 
the interactions that occur during the binding of Phd2 and Oln1. The DNA sequence to which Phd binds 
is highlighted with yellow, while interactions between DNA bases and protein are represented by green 
dotted lines. C) A schematic of the electropositive patch that is essential to the creation of the Oln1-Phd2 
complex (adapted from (24)). 
 
1.4.3 Transcription regulation of the phd/doc operon 
It is typical for TA operons to be autoregulated by their own translational products. In this 
case the Phd and Doc molecules can form different complexes depending on the molar 
ratio between the toxin and antitoxin molecules. Depending on this ratio, the 
toxin/antitoxin complex will or will not act as a repressor (29).  
The phd/doc operon has an operator region that contains two binding boxes (named Oln1 
and Oln2) to which the Phd dimers (Phd2) bind with their N-terminal regions. The C-
terminal region of Phd remains highly disordered if no Doc molecules are present. When 
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Phd2 binds to the first binding site, the disordered regions form a sterical barrier that 
prevents a second dimer to bind to the adjacent binding site. Full repression of the operon 
occurs only when a Phd dimer is bound to both sites (see Figure 7). Due to high negative 
cooperativity the binding of two Phd molecules on their own to the operator is disfavoured. 
Therefore, Phd cannot act as a full repressor of the operon in the absence of Doc (24). 
There are two Phd binding sites present on opposite sides of Doc. They both bind the C-
terminal part of the Phd molecules, but they differ in their affinity for them. One of them 
exhibits a higher binding affinity and is dubbed site H, while the other one with the lower 
affinity is dubbed site L. When two Phd2 molecules are bound to Doc, the distance 
between their DNA binding motifs is approximately 43Å which is also the length of the 
gap between the binding sites in the phd/doc operator region. Therefore, this complex is 
able to bind both Oln1 and Oln2 at the same time, consequently fully repressing the operon 
(24, 29). 
 
 
Figure 7: Structural representation of Phd/Doc complexes. Doc molecules are presented in blue and Phd 
monomers are presented in orange and red. A) A Phd2-Doc-Phd2 complex which binds strongly to the 
operator and derepresses it. B) A Doc-Phd2-Doc complex which cannot bind to the operator due to 
steric interference (PDB ID: 3k33). 
 
When two Phd dimers are bound to one Doc monomer, each of the dimers retains one free 
toxin binding site. Because of that, additional Doc molecules can be »caught« by their H 
sites by the bound Phd dimers. As the number of »caught« Doc molecules increases, their 
H sites eventually outcompete the L site on the Doc bridging two Phd dimers, so the 
complex breaks up. The new stable Doc-Phd2-Doc complex cannot bind to the operator 
region due to its steric properties and therefore repression of the operon stops. This triggers 
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the start of transcription and de novo synthesis of Phd that leads again to the formation of a 
repressing Phd2-Doc-Phd2 complex as shown in Figure 8. (29) 
When Doc binds to Phd, it also induces an allosteric change: folding upon binding of the 
IDR of Phd propagates towards the N-terminal DNA-binding domain, resulting in an 
increased affinity for the operator (29).  
 
 
Figure 8: Regulation of the phd/doc operon. Phd (shown as orange-red dimers) is present in an ordered 
and disordered conformation that are in an equilibrium. While Phd2 is not bound to Doc (shown in blue) 
a second Phd dimer is not able to bind to the DNA, due to the IDR of the bound dimer acting as an 
entropic barrier. Thus, full repression of the operator DNA is not possible. When Doc binds to the 
already DNA-bound Phd2, structuring of the antitoxin dimer enables a second dimer to bind to the toxin 
and the stable Phd2-Doc-Oln12 complex forms. When more Doc molecules bind to the formed complex 
onto the free Phd C-terminal domains, the repression of the operon is strengthened. In this way three 
toxin molecules can be bound onto two Phd dimers while still repressing the operon. However, when a 
fourth toxin molecule enters the complex its high affinity (marked as H) site outcompetes the low 
affinity (marked as L) site on the bridging Doc molecule and the repression able complex breaks apart. 
As proteases in times of stress degrade the antitoxin, Doc gets released and can act by phosphorylating 
the EF-Tu elongation factor (adapted from (24)).  
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2 RESEARCH PLAN 
It is known that Phd binds to two short palindromic sequences on the operator and that Doc 
modulates the affinity of Phd for this DNA sequence. The molecular basis for its operator 
specificity has not been studied yet. Neither is it known if Phd or the Phd/Doc complex 
directly affect the expression of other bacterial genes with a similar operator sequence as 
the one Phd recognizes. 
Phd is a highly flexible protein, the stability and dynamics of which strongly depend on 
environmental conditions, in particular ionic strength and its interaction with Doc. We 
wish to map the affinity of Phd for its operator sequence and the corresponding 
thermodynamic profile. 
In this project, the operator specificity of Phd will be investigated using isothermal titration 
calorimetry. Phd and Doc will be isolated as a heterogeneous complex from a prepared E. 
coli cell lysate. This complex will be separated into its components using an on-column 
unfolding/refolding procedure previously established in the lab of prof. Loris. The quality 
of the Phd preparations will be assessed using SDS-PAGE and circular dichroism 
spectroscopy. Simultaneously we will investigate the effect of the ionic strength of the 
buffer on the secondary structure composition of Phd with circular dichroism spectroscopy. 
To determine which buffer composition is optimal for the ITC experiments, we will carry 
out a thermal stability assay with a wide range of different buffers.  
Binding of Phd to a series of short DNA fragments containing the wild type 8 bp 
palindrome operator sequence as well as point mutants of it will be studied using ITC. The 
data will be analysed in the context of Phd crystal structure in a complex with a wild-type 
operator fragment. 
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3 MATERIALS, INSTRUMENTS AND METHODS 
3.1 Materials 
NaCl, NaH2PO4, Na2HPO4 – Carl Roth Gmbh 
Trizma base – Sigma-Aldrich 
Ethylene glycol – FLUKA analytical (Sigma-Aldrich) 
Gn•HCl – Sigma-Aldrich 
Glycerol – VWR prolabo chemicals 
MES monohydrate – Sigma-Aldrich 
Imidazole – Sigma-Aldrich 
HCl (37%) – VWR prolabo chemicals 
NaOH (10 M) – VWR prolabo chemicals 
30% acryl/bisacrylamide – Severn biotech 
Tris-HCl – Sigma-Aldrich 
SDS (sodium dodecylsulfate) – Sigma-Aldrich 
APS (ammonium peroxodisulfate) – FLUKA biochemica (Sigma-Aldrich) 
TEMED – Sigma-Aldrich 
Buffers used in purification of proteins: 
A 50 mM Tris, pH 8.0, 500 mM NaCl 
B 50 mM Tris, pH 7.5, 1 M NaCl, 10% ethylene glycol 
C 50 mM Tris, pH 7.0, 500 mM NaCl, 5.0 M Gn•HCl  
D 25 mM Tris, pH 7.5, 25 mM NaCl, 5% glycerol  
E 25 mM Tris, pH 7.5, 25 mM NaCl, 1% glycerol  
G 50 mM Tris, pH 7.5, 500 mM NaCl, 1 M imidazole 
Laemmli buffer pH 6.8:  
• 4% SDS 
• 10% 2-mercaptoethanol 
• 20% glycerol 
• 0.004% bromophenol blue 
• 0.125 M Tris-HCl 
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WB transfer buffer pH 8.3: 
• 0.025 M Tris base 
• 0.192 M Glycine 
• 20% methanol 
• 0.1% SDS 
WB membrane PVDF Transfer membrane 0.45 μm – Thermo Scientific 
WB antibodies:  
• Mouse anti-histidine tag – BIO-RAD 
• Anti-Mouse IgG (whole molecule) Alkaline Phosphatase antibody (produced in 
goat) – Sigma-Aldrich 
WB substrate – NBT/BCIP stock solution – Roche diagnostics GmbH 
5% (w/v) Blocking solution for WB (milk powder) 
Gel loading dye Nu Page (4×) – NOVEX 
Electrophoresis MW marker Page RulerTM prestained protein ladder – Termo Scientific 
Coomassie blue staining solution: 
• 0.1% (w/v) Brilliant Blue R-250 
• 25% (v/v) methanol 
• 5% (v/v) acetic acid 
Coomassie Destain solution: 
• 25% (v/v) methanol 
• 5% (v/v) acetic acid 
Oligonucleotides (for sequences see Table II) – Sigma-Aldrich 
Contrad 70 10% solution – Decon labs Inc. 
Amicon(R) Ultra Centrifugal filters Ultracel 3K – Merck Millipore 
Parafilm PM-996 – Bemis 
Gloves – Kimtech science brand green nitrile 
Filters Filtropur S 0.45 (µm) – SARSTEDT 
Serological pipettes CELLSTAR – Grenier Bio-One 
Eppendorf tubes: 
1.5 mL micro tubes – Sarstedt 
2.0 mL reaction tubes – Greiner Bio-One 
Falcon tubes CELLSTAR (15 mL, 50 mL) – Greiner Bio-One 
Tips Ultratip (1 mL, 200 µL) – Greiner Bio-One 
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Pipette boy Automatic-SARPETTE – Sarstedt 
serological pipettes – Sarstedt 
 
3.2 Instruments 
ÄKTA FPLC – GE Healthcare 
ÄKTA Purifier – GE Healthcare 
5 mL HisTrap™ HP Nickel-Sepharose column – GE Healthcare 
Superdex 75 16/60 HR gel filtration column – GE Healthcare 
UV-VIS Spectrophotometer NanoDrop spectrophotometer ND-1000 – Isogen life sciences 
Trans-Blot Turbo Transfer System – BioRad 
Spectropolarimeter J-715 – Jasco Corporation 
Laboratory scale – KERN PCB 
ITC machine MicroCal iTC 200 – Malvern Panalytical 
Vacuum degasser – TA instruments degassing station Model Nr. 6323 
Gel Electrophoresis: 
- Power-Pac Basic – Bio-Rad 
- Mini-Protean tetra cell system – Bio-Rad 
Dialysis cassettes Slide-A-Lyzer 3.5K – Thermo Scientific 
Centrifuge MF 20-R – Awel Centrifugation 
Centrifuge Micro CL17 centrifuge – Thermo Scientific 
pH meter PB-11 – Sartorious 
Vortex mixer – VWR Digital  
Magnetic stirrer VS-C7 – VWR 
CHEMI DOCTM XRS+ with image lab software – Bio-Rad 
Automatic pipettes m1000, m200, m20 – BIOHIT 
Thermoblock thermomixer comfort – Eppendorf 
Water supply Milli-Q – Millipore  
CFX96 RealTime PCR System – BioRad 
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3.3 Methods  
3.3.1 Purification of Phd/Doc complex by affinity chromatography  
The Phd/Doc complex was purified from a frozen cell lysate of Escherichia coli (BL21 
(DE3) strain) expressing his-tagged Doc protein, following a procedure established by 
Sterckx et al. (30). First, the lysate was thawed in warm water. During the unfreezing 
process, the ÄKTA FPLC was readied by running the pump wash program for pumps A 
and B. Both were first washed with MilliQ water. Pump A was then washed with 50 mM 
Tris, pH 8.0, 500 mM NaCl (buffer A) and pump B with 50 mM Tris pH 7.0, 500 mM 
NaCl, 5.0 M Gn•HCl (buffer C). 
Next, the sample pump was cleaned using the following cleaning solutions: 
1. 1 M NaOH, 1 M NaCl 
2. 200 mM Tris, pH 8 
3. 70% EtOH 
4. 20% EtOH 
After the cleaning step, the sample pump was washed with 50 mM Tris, pH 8.0, 500 mM 
NaCl (buffer A) with a flow rate of 5 mL/min. Following this, the cell lysate was 
centrifuged at 16000 RPM, 45 min at 3 ºC. The supernatant was filtered into another falcon 
tube using a SARSTEDT Filtropur S 0.45 µm filter. The pellet was discarded. During the 
centrifugation of the cell lysate, a column wash program was started to wash the Ni-
Sepharose column (GE Healthcare 5 mL HisTrap™HP) with five column volumes (CV) of 
buffer A with a flow rate of 2 mL/min. 
After the column wash, the filtered cell lysate supernatant was loaded onto the column 
using the sample pump and the sample loading program. The following steps were all 
carried out with a flow rate of 0.5 mL/min. The column was again washed with 2 column 
volumes of buffer A. To wash out weakly bound contaminants the column was washed 
with 50 mM Tris, pH 7.5, 1 M NaCl, 10% ethylene glycol (buffer B) until the OD at 280 
nm stabilised. The interaction between Phd and Doc was disrupted by using a 1:1 mixture 
of buffer B and buffer C to cause denaturation of both proteins. The first peak during this 
elution step was the weaker bound Phd molecule (dubbed Phd1). After Phd1 was eluted, 
the concentration buffer C in the mixture was increased to 100% to elute the stronger 
bound Phd molecule (dubbed Phd2). After all of the Phd molecules left the column, an on-
column refolding step was used to return Doc into the correct conformation. To achieve 
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this, the column was washed with 10 column volumes of 25 mM Tris, pH 7.5, 25 mM 
NaCl, 5% glycerol (buffer D) and 10 column volumes of 25 mM, Tris pH 7.5, 25 mM 
NaCl, 1% glycerol (buffer E). Following these steps, the column was washed with one 
column volume of buffer A, after which the elution of Doc was carried out employing a 
linear gradient of buffer A and 50 mM Tris, pH 7.5, 500 mM NaCl, 1 M imidazole (buffer 
G). When the composition of the buffer mixture increased up to 20% of buffer G, the 
weaker bound molecules of Doc (dubbed Doc1) left the column. After that percentage was 
reached, the concentration of buffer G was increased to 100%. This caused even the 
strongly bound Doc molecules (dubbed Doc2) to elute from the column. 
The content and purity of the collected fractions of Phd and Doc was resolved by running a 
15% SDS-PAGE. The fractions containing the distinct proteins were pooled and dialysed 
at room temperature overnight against the gel filtration buffer to prevent precipitation. 
 
3.3.2 Purification of Phd/Doc complex by size exclusion chromatography 
The ÄKTA FPLC was prepared for gel filtration by running a pump wash program first 
with water and then with GF buffer (100 mM Na2HPO4, pH 6.5, 200 mM NaCl). The 
Superdex 75 16/60 HR-gel filtration column was also washed with one column volume of 
GF buffer at flow rate of 1.5 mL/min. While the column was being washed, the IMAC 
(immobilized metal affinity chromatography) fractions containing Phd1 were pooled, and 
the same was done for the IMAC fractions containing Phd2, Doc1 and Doc2. The pooled 
fractions were then concentrated to the volume of 2 mL with centrifugation at 3230 g for 
approximately 20 minutes in the centrifuge MF 20-R (Awel Centrifugation) using Amicon 
Ultra-15 concentrator falcon tubes with MWCO of 3.5 kDa.  
The concentrated samples were then each separately injected onto the column and were run 
with the GF buffer with a flow rate of 1.5 mL/min. With this step, any remaining 
impurities were removed. The purity of the proteins was again assessed by running a 15% 
SDS-PAGE. The pure fractions of Phd1 and Phd2 were pooled. The Doc1 and Doc2 
fractions were also pooled. The protein concentrations of the pooled fractions of Phd and 
Doc were determined with the use of a NanoDrop spectrophotometer ND-1000 at 280 nm. 
The samples were then divided into aliquots of 1 mL and frozen in liquid nitrogen. They 
were then stored at -20 °C in a freezer. 
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3.3.3 SDS-PAGE analysis of purified proteins 
The SDS-PAGE gel was prepared according to the following recipe:  
Table I: 15% SDS-PAGE Gel composition (8 gels) 
Separating gel Volume (mL) Stacking gel Volume 
(mL) 
30% acryl/bisacrylamide 24 30% acryl/bisacrylamide 4 
1.5 M Tris-HCl pH 8.8 12 1.5 M Tris-HCl pH 8.8 3 
H2O 11 H2O 16.5 
10% SDS 0.480 10% SDS 0.240 
10% APS 0.480 APS 0.240 
TEMED 0.048 TEMED 0.024 
 
The glass plates used to pour the gel were washed with MilliQ water, wiped with 70% 
ethanol and dried. After they were dry, the eight glass plates pairs were affixed into a 
scaffold and the separating gel was poured into them and overlaid with isopropanol. It was 
left to solidify at room temperature for approximately 20 minutes. After it hardened, the 
stacking gel was poured on top of it. Immediately after the stacking gel was poured, combs 
were inserted into the still liquid gel to ensure the formation of wells. As the stacking gel 
solidified, the prepared gels were wrapped in wet paper towels and stored at 4 °C until 
further use. 
To prepare samples for SDS-PAGE electrophoresis, 16 µL of each sample was pipetted 
into a microcentrifuge tube, and 4 uL of loading dye was added. The mixtures were then 
boiled at 99 °C for 2 minutes and centrifuged at 6200 g for 2 minutes. 
Before use, the gel was taken out of the cold room and unwrapped. It was then affixed into 
the scaffold that secured it during the running procedure. If only one gel was being used, 
the remaining slot in the scaffold was filled with a plastic electrophoresis dam. The 
scaffold was then inserted into a Bio-Rad mini-Protean tetra cell electrophoresis chamber 
which was then filled with Laemmli buffer.  
The comb was removed from the gel and samples were pipetted into the wells. The first 
well contained 2 µL of a molecular weight marker, while the other wells contained 15 µL 
of the corresponding samples. 
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The electrophoresis chamber was then covered and connected to the power supply, a Bio-
Rad Power-Pac Basic system. The gel was run at 190 V and 400 mA until the dye front 
reached the end of the gel (approximately 60 minutes). After the run finished, the gel was 
carefully removed from the glass plates and stained with Coomassie brilliant blue for at 
least 30 minutes. The gel was then destained using the Coomassie destain solution, which 
was replaced every 30 minutes for three cycles. The bands visible on the gel were then 
photographed using the CHEMI DOCTM XRS+ machine. 
 
3.3.4 Western blot 
Following SDS-PAGE, the gel was transferred to the western blot transfer buffer instead of 
being dyed with Coomassie brilliant blue. While the gel was in the buffer, six pieces of 
filter paper and a piece of WB membrane were cut to the same size as the gel. The filter 
paper was then wetted with the WB transfer buffer. Three pieces of the paper were put on 
top of each other in the WB cartridge. The membrane was activated by washing with 
methanol and was placed on top of the stack of papers. The gel was placed on top of the 
membrane and was covered with a stack of the remaining three pieces of filter paper. A 
roller was used to remove air bubbles, the WB cartridge was closed and inserted into the 
WB machine where it was run for 11 minutes at 2.5 A and 25 V. 
After the electrotransfer program finished, the membrane was removed from the assembly 
and put into PBS buffer. The gel and filter papers were discarded. The PBS buffer in the 
container with the membrane was replaced with a 5% blocking solution in PBS with which 
the membrane was blocked for 30 minutes. After 30 minutes passed, the membrane was 
washed with PBS three times and incubated with 10 mL of goat anti-his antibody 1:1000 
solution in 5% milk. After 20 minutes the membrane was washed again with PBS three 
times and then incubated with 10 mL of mouse anti-goat antibody-alkaline phosphatase 
conjugate diluted 1:1000 in 5% milk. After another 20 minutes the membrane was washed 
again with PBS three times after which 10 mL of WB blotting buffer and 50 µL of the 
NBT/BCIP chromogenic substrate stock solution was added to the membrane. After 
approximately 5 minutes the solution was removed and replaced with MilliQ water. The 
bands in which Doc molecules marked with his-tag were present have turned a dark brown 
colour. The bands visible on the membrane were then photographed using the CHEMI 
DOCTM XRS+ machine. 
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3.3.5 Concentrating samples 
The Amicon Ultra-15 concentrator tubes with MWCO of 3.5 kDa were first washed with 
MilliQ water by centrifugation at 3230 g and 4 °C for 10 min. This was carried out to wash 
the membranes present in the tubes. After the washing was carried out, up to 15 mL of 
sample was added into the concentrator tube. The samples were then centrifuged at 3230 g 
and 4 °C for 20-40 minutes, depending on sample volume and desired volume of 
concentrate. The centrifugation step was repeated several times if the desired volume of 
sample was not achieved. 
 
3.3.6 Dialysis and storage 
The dialysis of samples was carried out by using a Slide-A-Lyzer 3.5K MWCO dialysis 
cassette. It was filled with up to 0.5 mL of sample and closed. Then a foam floater was 
affixed onto the top of the cassette and it was put into a beaker filled with the desired 
buffer and containing a magnetic stirrer. The volume of the buffer varied from 1 L to 5 L, 
depending on the number and size of dialysis cassettes used. The beaker was then covered 
with parafilm to prevent evaporation of water and kept on a magnetic stirrer overnight at 
room temperature. 
 
3.3.7 Circular dichroism spectroscopy 
To assess the secondary structure elements of purified Phd samples, circular dichroism 
spectroscopy was used. This technique utilises the phenomenon of chiral chromophores, 
where they absorb the L and R components of plane polarised light in an unequal extent. 
This unequal absorbtion leads to elliptically polarised light with different R and L 
polarised components. This can be detected and measured in a spectropolarimeter (31).  
Protein samples were dialysed against selected buffers. The conformation of Phd was 
investigated in the following buffers: Buffer 1 – 20 mM Na2HPO4, 50 mM NaCl, pH 6.9, 
Buffer 2 – 20 mM Na2HPO4, 150 mM NaCl, pH 6.9 and Buffer 3 – 20 mM Na2HPO4, 500 
mM NaCl, pH 6.9. This was done to assess the influence of increasing ionic strength on the 
secondary structure element composition of Phd. Following dialysis overnight, the samples 
were filtered with a 0.45 µm filter. Before the measurement, the amount of available N2 
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gas had to be checked to flush the machines' system. The powerful lamp causes ionisation 
of O2 to ozone, which causes the mirrors inside the device to deteriorate. Next, the first of 
the buffers was pipetted into a clean cuvette with a width of 0.1 cm, to give a baseline to be 
used to normalise sample measurements. For each sample, a buffer measurement was 
followed by measurement of the protein in the same buffer. CD spectra were acquired in 
the wavelength range from 260 nm to 180 nm, with a bandwidth of 1 nm and a data pitch 
of 0.5 nm. When the measurements were completed, the cuvette was emptied, and its 
interior filled with chromic acid to remove all traces of the previous protein sample. After 
approximately 10 minutes the acid was removed, the cuvette was thoroughly rinsed with 
MilliQ water and dried with air. For each condition the signal from the buffer was 
subtracted from that of the sample. 
  
3.3.8 Thermal stability assay 
Thermal stability of Phd in different buffers was investigated using the Themofluor Assay 
method, as proposed by Ericsson and co-workers (32). This method enables the 
identification of favourable buffer conditions in which the protein is highly stable. In this 
assay, a hydrophobic flourescent dye is added to a solution of the investigated protein 
which is then gradually heated until the protein denatures. The dyes flourescence is 
quenched while dissolved in water, but it emits flourescence when bound to the exposed 
hydrophobic regions of the unravelling protein. Measuring this flourescence signal enables 
the calculation of the melting point temperature (Tm) (33).  
A wide range of buffer compositions was tested, consisting of sodium phosphate buffer 
and Tris at 20 mM or 100 mM concentration. The buffers also varied in salt content, 
having NaCl concentrations from 20 mM to 500 mM. The effect of pH was also studied, 
with pH ranging from 6.0 to 8.0. 
A 96-well opaque PCR plate which enables the PCR machine to discern and measure the 
flourescence in each well separately was used. First, each well on the plate was filled with 
20 µL of buffer (with each well containing a different buffer), then 5 µL of a 50:50 mixture 
of 5X SYPRO orange solution and a solution of Phd was added, as described by Boivin et 
al. (33). This mixture was prepared just before addition into the wells, since the dye can 
cause unravelling of the protein if they are in contact for a prolonged time.  
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The 96 well plate was then inserted into a PCR block where it was first cooled down to 5 
ºC and then heated up to 95 ºC with an interval of 0.5 ºC per minute. Because of the rise in 
temperature, the proteins in the wells denatured and the dye bound to them started emitting 
fluorescence. This fluorescence signal and its intensity provided information about which 
buffer conditions stabilised the Phd molecules the most.  
 
3.3.9 Isothermal titration calorimetry 
The measurement of the thermodynamic interactions between DNA and Phd was done 
with an isothermal titration calorimeter. A simplified schematic of an isothermal titration 
calorimeter is shown in Figure 9 below. The calorimeter consists of a sample and a 
reference cell, which are disc-shaped and contained in an adiabatic jacket. The reference 
cell contains a buffer or water, while the sample cell contains a solution of a 
macromolecule. Each of the cells has its own heater element which controls the 
temperature in the cell. Between the cells is a thermoelectric device, which measures the 
difference in temperature (ΔT). There is a low amount of power, less than 1 mW, being 
supplied to the reference cell through its heater whilst an experiment is running. This 
triggers a feedback circuit which activates the heater on the sample cell, which creates a 
baseline signal for the experiment. The ligand is injected into the sample cell through a 
high-precision syringe that has a stirrer element on the end. This ensures thorough mixing 
of the solution shortly after an injection is made. Upon injection of a ligand solution into 
the sample cell, heat is either released (exothermic reaction) or taken up (endothermic 
reaction) when the two investigated macromolecules interact. The observable signal is the 
required power input to the sample cell heater to maintain the temperature difference 
between the cells at ΔT=0 (34). 
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Figure 9: Isothermal titration calorimeter schematic. The basic elements of the calorimeter are marked in 
the figure (adapted from (35)). 
 
3.3.9.1 Sample preparation 
To prepare the protein samples for ITC measurements, they were first concentrated, and 
then dialysed overnight following the above described procedures. The dialysis buffer used 
was composed of 100 mM NaH2PO4 and 100 mM NaCl at pH 7.5. The sequence of the 5' 
strand reference oligonucleotide (wtOlnG), which is identical to the Phd binding site is 5-
CTTGTGTACACATG-3. The bold part represents the Phd binding site. The sequences of 
the tested oligonucleotides are shown in Table II.  
 
Table II: Sequences of investigated 5' single strand mutant oligonucleotides. Phd binding sites are 
shown with bold letters. The green coloured letters highlight the mutated bases. 
OlnG1A/T OlnG1G/C 
5-CTTATGTACAAATG 5-CTTGTGTACAGATG 
OlnG2A/T OlnG2G/C 
5-CTTGTGTACTCATG 5-CTTGGGTACGCATG 
OlnG3A/T OlnG3G/C 
5-CTTGTATAAACATG 5-CTTGTCTACACATG 
OlnG4A/T OlnG4G/C 
5-CTTGTGTTCACATG 5-CTTGTGCCCACATG 
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Candidate single strand oligonucleotides were ordered from Sigma-Aldrich and were 
supplied in a dehydrated state. The oligonucleotides were resuspended in MilliQ water to 
the concentration of 20 µM. The 5' and 3' complimentary oligonucleotides were then 
combined in microcentrifuge tubes in a 1:1 volumetric ratio. Following this, the tubes 
containing the mix of single stranded oligonucleotides were heated to 80 ºC and incubated 
for 20 minutes. After the incubation finished, they were left to slowly cool down at room 
temperature. This was done to anneal the single stranded oligonucleotides into two 
stranded oligonucleotides to which Phd can bind. 
After the oligonucleotides were annealed, the concentrations of Phd and the 
oligonucleotides were measured using the NanoDrop spectrophotometer at 280 nm. The 
Phd samples were aliquoted to 70 µL. The oligonucleotide samples were stored in 
microcentrifuge tubes and marked accordingly to their contents. Three 50 mL falcon tubes 
were filled with the dialysis buffer which was filtered with a 0.45 µm filter. The buffer was 
later used to clean the reference and sample cells of the ITC machine between different 
experiments, or to dilute the samples if necessary. 
 
3.3.9.2 ITC apparatus preparation 
Before measurements could be made, the ITC apparatus had to be washed. The syringe 
wash (long) program was started form the software (Instrument Controls tab) and the 
onscreen instructions were followed. While the syringe was being washed, the sample cell 
was filled with a 10% decon 70 solution. When the syringe wash finished, the sample cell 
was emptied and washed twice with MilliQ water. Then, the sample cell wash (water) 
program was run and the onscreen instructions were followed. After the wash of the cell 
was done, it was rinsed with the filtered dialysis buffer. This was done by filling and 
emptying the sample cell with the buffer a few times. These steps were carried out after 
each measurement to ensure the cleanliness of the sample cell. If artefacts appeared during 
the titrations, the sample cell was soaked with 10% decon solution for a longer time before 
washing. 
 
3.3.9.3 Measurements 
An oligonucleotide solution of 20 µM with a volume of 300 µL was used for the 
experiments. To dilute the stock oligonucleotide solution, the filtered buffer was used, 
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since buffer mismatch adversely affects ITC titrations. After the oligonucleotide solution 
was diluted using the filtered buffer, it was degassed together with a Phd aliquot in the 
vacuum machine for approximately 5 minutes. The temperature of the degasser was set to 
the same value as the temperature of the sample cell, as a difference of more than 10 ºC 
can induce formation of gas bubbles in the sample solution, which causes artefacts. 
After the degassing, the Phd sample was loaded into the ITC syringe using the protocol set 
in the machine. The concentration of the Phd samples was 308 µM. While the Phd sample 
was being loaded, the sample cell was filled with the oligonucleotide sample solution. We 
made sure to finish the injection of the sample with vigorous moving of the syringe 
plunger up and down, to dislodge any bubbles that were trapped in the sample cell. After 
the ITC syringe was filled, it was lifted out of the tube containing the Phd sample and 
wiped with a medical wipe to remove any protein sample on the outside of the syringe. 
When the cell and syringe were filled, the FPA (Fill Port Adaptor) tubing was unscrewed 
from the ITC syringe. The syringe was then inserted into the reaction cell. 
Before starting the experiment, the experimental parameters such as temperature, dP 
(differential power – a constant power supply to the heater element between cells to ensure 
stable cell temperatures), stirring speed, concentration in the cell and in the syringe were 
checked and modified if necessary. The volume of the Phd solution injected was 2 µL per 
injection into the sample cell (200 µL) and eighteen injections were carried out per 
experiment. The stirring speed was set to 750 rpm throughout all experiments.  
After we started the experiment, the ITC machine started equilibrating the sample and 
reference cell temperatures until it reached the value specified in the AED tab. As the 
target temperature was reached and stable, the final baseline calibration started. This was 
needed for the Reference Power (µCal/sec) to reach the specified value and enable us to 
carry out the measurements. When the baseline stabilised, we double clicked the Reference 
Power display window in the Real Time Plot to start the titration.  
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4 RESULTS AND DISCUSSION 
4.1 Purification of Phd 
The purification of Phd was carried out following an already established procedure by 
Sterckx and co-workers (30). First, the Phd and his-tagged Doc protein complex was co-
expressed in E. coli BL21(DE3) and the Phd/Doc complex was bound onto a Ni-NTA 
column. After the column was loaded with the cell lysate, firstly various impurities were 
flushed from it with 50 mM Tris, pH 7.5, 1 M NaCl, 10% ethylene glycol (buffer B). This 
caused the OD at 280 nm to rise steeply as proteins and other impurities left the column. 
After 2 column volumes (CV), the OD at 280 nm fell back close to 0 and started to 
stabilise, which signified that there are no more weakly bound contaminants on the 
column. When the OD stabilised, the elution of Phd from the column was started by 
applying a 1:1 mixture of 50 mM Tris, pH 7.5, 1 M NaCl, 10% ethylene glycol (buffer B) 
and 50 mM Tris, pH 7.0, 500 mM NaCl, 5.0 M Gn•HCl (buffer C) in a step gradient that 
increases the guanidinium chloride concentration from 0 M to 2.5 M in the first step, and to 
5 M in the second step. Shortly after the increase of guanidinium chloride concentration in 
the buffer mixture, a peak appeared on the chromatogram (shown in Figure 10) which 
contained Phd (dubbed Phd1). To dislodge the stronger-bound Phd, the concentration of 
guanidinium hydrochloride was increased to 5 M. Soon after that, a second peak appeared 
which contained Phd molecules (dubbed Phd2) (Figure 10). This phenomenon is due to the 
existence of two Phd binding sites on the Doc molecule with differing affinities (29). 
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Figure 10: Purification of Phd using a Ni-NTA column. The blue line represents the absorbance @ 280 
nm, while the orange one shows the concentration of guanidinium hydrochloride in the buffer mixture 
gradient. The broad peak marked as impurities contains the unwanted proteins washed off the column 
using buffer B. The peaks marked Phd1 and Phd2 contain the respective proteins. 
 
Having extracted Phd, the refolding of Doc was started immediately on column with the 
use of 25 mM Tris, pH 7.5, 25 mM NaCl, 5% glycerol (buffer D) and 25 mM Tris, pH 7.5, 
25 mM NaCl, 1% glycerol (buffer E). The glycerol in the used buffers stabilises the 
unfolded Doc molecules and enables them to gradually refold in their proper forms. To 
elute Doc from the column a gradient of 50 mM Tris, pH 7.5, 500 mM NaCl, 1M 
imidazole (buffer G) was used. Due to the high concentration of imidazole in this buffer 
and its high affinity for the Ni-NTA column it displaces the his-tagged Doc on the binding 
sites and causes Doc to elute. The gradient was slowly increased, until the concentration of 
imidazole in the buffer mixture reached 0.2 M. At approximately 0.1 M imidazole 
concentration, the first peak which contained Doc (dubbed Doc1) eluted. After the 
concentration of imidazole in the buffer mixture reached 0.2 M, it was increased to 1 M, 
which caused the elution of the second peak containing Doc dubbed Doc2 (see Figure 11). 
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Figure 11: Elution of Doc from the column. The blue line represents the absorbance @ 280 nm, while 
the orange one shows the % of buffer G in the gradient. The marked peaks contain Doc1 and Doc2 
respectively. 
 
The purified proteins were resolved by SDS-PAGE. The results of the SDS-PAGE and 
western blot of the Doc elution step are shown in Figure 12. The bands from the Doc peak 
samples are very broad, probably due to the presence of partially degraded Doc molecules 
that travel at a similar rate than intact Doc molecules. At first it was suspected that the faint 
bands below the Doc bands in lanes 7 through 12 in Figure 12(A) are remnants of Phd that 
was not successfully eluted from the column. This was later refuted after obtaining the gel 
displayed in Figure 14, where it is shown that Phd travels with the 10 kDa MW marker. 
Possibly these bands contain Doc molecules that lost their His-tag after being eluted as 
they are not visible on the Western blot that was ran in parallel with the SDS-PAGE gel. 
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Figure 12: A: SDS-PAGE of the purified Doc. On lane 0 is the MW marker, with depicted MW values 
for each band. Lanes 1 and 2 contain samples of the impurities that eluted before the Doc peaks. The 
rest of the bands, from 3 to 12, belong to samples from the peaks of Doc1 and Doc2. The bands 
containing Doc are very broad, which indicates that some impurities are still present. B: A western blot 
of a gel run in parallel with identical samples in the same lanes as in part A of this figure. The lane 0 
contains the MW marker with depicted MW values for each band. It shows that there is a very low 
amount of Doc present in the lanes 1 and 2. It also confirms the presence of Doc in the remaining lanes, 
as Doc is the only protein with a his-tag present in these samples. 
 
The Phd solution obtained by the affinity chromatography was further purified by size-
exclusion chromatography using a Superdex 75 16/60 HR column. As shown in Figure 13, 
only one peak was present, which contained pure Phd. The fractions of the pure Phd were 
then pooled and ran on a 15% SDS-PAGE gel to confirm the purity of the isolated Phd. 
The results of the gel run are shown in Figure 14. 
32 
 
 
Figure 13: Size exclusion chromatography of Phd. The blue line represents the absorbance @ 280 nm. 
The peak contains concentrated Phd. The numbers above the X-axis represent the intervals at which the 
flow from the column was fractioned. The fractions from 21 to 25 were pooled and used for further 
experiments. 
 
 
Figure 14: SDS-PAGE of the pooled purified Phd fractions of the size exclusion chromatography. Due 
to the low molecular weight of Phd (8.3 kDa), it travels with the 10 kDa marker in line with the dye 
front. As there are no other bands present on the gel this confirms that we successfully purified the Phd 
protein.  
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4.2 Assessment of secondary structure with Circular dichroism 
spectroscopy 
To confirm the integrity of the isolated Phd molecules, the secondary structure 
composition of the protein was assessed using circular dichroism spectroscopy. As it was 
postulated that the secondary structure composition of Phd changes in accordance with 
ionic strength of the buffer (29), the measurements were carried out in three buffers with 
differing ionic strength. 
The mean residue ellipticity (θn [deg cm
2 dmol-1]) was calculated using the following 
equation 
Equation 1: Mean residue ellipticity 
𝜃𝑛 =
𝜃 ×𝑀𝑅𝑊
10 × 𝑐 × 𝑙
 
 
where MRW is the mean residue weight of Phd [Da], 𝜃 is the measured ellipticity [mdeg], c 
is the protein concentration [mg/ml] and l is path length [cm].  
The mean residue weight (MRW) used in equation 1 is calculated with the equation shown 
below 
Equation 2: Mean residue weight 
𝑀𝑅𝑊 =
𝑀𝑀
𝑛 − 1
 
where MM is the molecular mass of the protein (g/mol) and n is the number of amino acids 
in the protein (31). 
The calculated mean ellipticity was plotted with Excel (Figure 15) to visualise the 
differences in secondary structure among the configurations in the selected buffers. Due to 
the presence of Cl- ions in the buffer used, measurements below 200 nm are too noisy to be 
of use. This is because Cl- ions exhibit high absorbance in the far UV range (31). The 
differing content of Cl- ions in the buffers is also thought to be the cause of the scale 
differences in the measured ellipticity, as the buffer with the highest content of Cl- has by 
far the highest measured ellipticity.  
From the graph shown below in Figure 15, differences (albeit small) can be seen between 
the shape of the curves measured in the selected buffers. According to our expectations and 
knowledge of the secondary structure elements of Phd (24), the curves show a motif 
associated with α-helices (31). 
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Figure 15: Molar ellipticity per amino acid residue of Phd. The shape of the curves indicates the 
secondary structure of Phd is made up of predominantly α-helices. 
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4.3 Environmental dependence of the thermal stability of Phd 
It was previously suggested that the structure and thermodynamic stability of Phd is highly 
context dependent, and especially depends on the ionic strength of the buffer (29). To 
further test this hypothesis and to determine the best buffer in which to do the DNA 
binding experiments, the thermodynamic stability of Phd was evaluated in a medium 
throughput assay using the thermofluor method proposed by Ericsson and co-workers (32). 
The melting point temperature of the protein can be determined from the raw data output 
of the CFX96 RealTime PCR System. This is achievable either by visually determining the 
inflection point of the sigmoid melt curve, or by calculating the zero of the second 
derivative of the melt curve (33). To expedite the data analysis process, a Microsoft Excel 
script suite named DSF Analysis 3.0.2. developed by Niesen and colleagues (36) was used.  
First the raw data output from the CFX96 RealTime PCR System was transformed into a 
format which is understood by the script. To obtain the melting point temperature, fitting 
of the data was carried out with the with the Boltzmann equation shown below in the 
program GraphPad Prism 8. 
 
Equation 3: Boltzmann equation used to fit the melt curves 
𝐼 = (𝐼𝑠 +
(𝐼𝑓 − 𝐼𝑠)
1 + ⅇ
(𝑇𝑚−𝑇)
𝑘
) 
 
Here I is the intensity of the measured fluorescence [RFU] at the temperature T [ºC], Is is 
the starting baseline fluorescence intensity [RFU] while If is the peak intensity of 
fluorescence after the protein melts [RFU]. Tm is the melting point temperature [ºC] where 
the ratio between the intact and denatured protein is 1:1, and k is the slope factor of the 
curve [ΔRFU/ºC] (32). After the Boltzmann equation fitting was carried out in GraphPad 
Prism 8, the output from the program was pasted back into the script which processed the 
data and returned the measured Tm and the calculated ΔTm, if a reference buffer was 
chosen.  
The results of this thermal stability assay are shown below in Figure 16. Only the four best 
buffers which had the highest melting point temperature (Tm) are presented. The exact 
composition of these buffers is also shown in Figure 16. Two of the »best« buffers have 
low salt content (20 mM and 50 mM), while two have high salt content (400 mM and 500 
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mM). With regard to buffer molarity, the first three have a lower molarity (20 mM) while 
the fourth has a higher molarity (100 mM). Interestingly, three of the best buffers contain 
Tris, which could point to increased stability of Phd in Tris buffers. On the other hand, the 
Tm of all the shown buffers in very close range, therefore more experimentation is required 
to confirm or refute this. The Tm of Phd in the four selected buffers, which is shown in 
Figure 16, is only 1 °C above the average measured Tm (57.11 °C) of all 96 tested buffers. 
The composition of these »best« buffers is also not uniform. There does not seem to be any 
discernible connection between the increase in melting point temperature and the molarity 
and salt content of the buffer. These unclear results can also partly be attributed to the 
intrinsically disordered region (IDR) of Phd, since it makes up a large part of the protein 
and binds the Sypro Orange dye used in this experiment regardless of the temperature (37). 
This would also explain the high baseline fluorescence values shown in our experiment 
(~4700 RFU) compared to the measurements done by Ericsson and co-workers (~1500 
RFU) (32). While it is thought that the IDR coils into a more ordered conformation while 
in solutions with a higher salt concentration (29), this could not be confirmed using the 
experimental technique at hand.  
 
Figure 16: Effect of differing buffer molarity, salt content and pH on the thermal stability of Phd. 
Curves shown represent the measurements obtained in the buffers with most stable Phd. The calculated 
Tm in each buffer is shown as a data callout for every curve. 
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4.4 Assessment of the binding thermodynamics of Phd and 
operator sequences using isothermal titration calorimetry 
The phd/doc toxin-antitoxin module from E. coli bacteriophage P1 is virtually identical to 
the chromosomal phd/doc of Salmonella. The latter is known to contribute to the formation 
of nonreplicating Salmonella persisters in macrophages (21). To understand the 
mechanisms involved in this route towards persistence, the regulation of the phd/doc 
operon, and thus the binding of Phd to its operator sequence is an important aspect. 
Therefore, the binding of Phd to operator DNA fragments was studied using isothermal 
titration calorimetry. Next to binding to the wild-type DNA sequence, a systematic 
mutagenesis study was conducted where each of the 8 positions in the 8 bp palindrome that 
is recognized by Phd was substituted to the three alternative bases. 
The results of the isothermal titration calorimetry experiment are shown in Table III below. 
In these tables, the 8 bp palindrome recognized by Phd is shown in bold, and the mutations 
introduced in the DNA are shown in green. The measurements presented in both tables 
were done at 298.15 K. 
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Table III: Results of the ITC measurements between Phd and the mutant oligonucleotides. Columns show the oligonucleotide name and sequence, the measured affinity 
(Kd), change in enthalpy (ΔH) and stoichiometry of the binding reaction (n). The calculated change in entropy times temperature (TΔS) and the change in free Gibbs 
energy (ΔG) are also shown. The bold letters in the oligonucleotide sequences show the Phd binding box, while the green letters mark the base pairs that were mutated. 
Oligonucleotide names and sequences Affinity [nM] ΔH [kCal/mol] TΔS [kCal/mol] n ΔG [kCal/mol] 
OlnG  5-CTTGTGTACACATG-3 
  3-GAACACATGTGTAC-5 
87 -2.8 6.8 0.9 -9.6 
Oln1A/T 5-CTTATGTACAAATG-3 
  3-GAATACATGTTTAC-5 
No binding detected 
Oln1G/C 5-CTTGTGTACAGATG-3 
  3-GAACACATGTCTAC-5 
1570 -0.4 7.5 1.0 -7.9 
Oln2A/T 5-CTTGTGTACTCATG-3 
  3-GAACACATGAGTAC-5 
348 -2.3 6.5 0.9 -8.8 
Oln2G/C 5-CTTGGGTACGCATG-3 
  3-GAACCCATGCGTAC-5 
377 -1.5 5.9 0.9 -7.4 
Oln3A/T 5-CTTGTATAAACATG-3 
  3-GAACATATTTGTAC-5 
No binding detected 
Oln3G/C 5-CTTGTCTACACATG-3 
  3-GAACAGATGTGTAC-5 
895 0.9 9.2 1.0 -8.2 
Oln4A/T 5-CTTGTGTTCACATG-3 
  3-GAACACAAGTGTAC-5 
19000 3.0 9.4 1.0 -6.4 
Oln4G/C 5-CTTGTGCCCACATG-3 
  3-GAACACGGGTGTAC-5 
755 1.9 8.8 1.0 -7.0 
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Figure 17 below shows the ITC curve of the reaction of Phd and with type OlnG. The 
peaks of the first few injections are present, because of heat that was expelled due to the 
binding process of Phd and DNA. As more Phd is injected into the DNA solution, fewer 
DNA molecules are available for binding, and thus less heat is released. After all DNA 
molecules are saturated with Phd, no more binding occurs. Yet, there are still peaks 
present, albeit small. This is a result of the heat of dilution of the injected Phd into the 
solution.  
 
 
Figure 17:Titration of Phd into wtOlnG. The top graph shows the raw ITC titration data and the bottom 
part of the figure shows the integral of enthalpy with time plotted against the molar ratio of Phd and 
OlnG. The slope of the sigmoid curve describes the association constant Ka, which is shown in light 
blue. The inflection point of the curve gives us information about the stoichiometry of the reaction N, 
which is shown in light green. Finally, the amplitude between the first few injections and the last few 
gives us the change in enthalpy ΔH, which is shown in red. 
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The measured association constant Ka is easily converted to the dissociation constant Kd 
with equation 4 below. 
Equation 4: Dissociation constant 
𝐾𝑑 =
1
𝐾𝑎
 
After the Kd is known, change in Gibbs free energy can be readily calculated with the 
following equation: 
Equation 5: Change in Gibbs free energy 
ΔG = R ∗ T ∗ ln𝐾𝑑 
where ΔG is the change of Gibbs free energy of association [J/mol], R is the gas constant 
[J/mol K-1], T the temperature at which the experiment was ran [K] and Kd being the 
dissociation constant [mol]. The measurements give us direct information on the change in 
enthalpy, from which we can calculate the change in entropy using the equation: 
 
Equation 6: Change in Gibbs free energy 
ΔG = ΔH − ΔS ∗ T 
where ΔG is the change of Gibbs free energy of disassociation [J/mol], ΔH is change in 
enthalpy [kcal/mol], ΔS is change in entropy [cal/mol K-1] and T is the temperature of the 
experiment [K]. 
As can be deduced from the results presented in Table III, all the mutant oligonucleotides 
that exhibit binding have worse binding properties that wtOlnG. An example of this is 
presented in Figure 18 below. It shows the ITC curve of the Phd into Oln2A/T experiment. 
As the binding affinity is much lower compared to wtOlnG the DNA molecules become 
saturated with Phd much sooner. As can be seen in the Figure 18, after four injections of 
Phd most of the DNA molecules were already saturated. There is also less released heat, 
thus the change in enthalpy is lesser. The sigmoid curve in the lower graph of the Figure 18 
is also less pronounced compared with wtOlnG. 
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Figure 18: Titration of Phd into Oln2A/T. The top graph shows the raw ITC titration data and the 
bottom part of the figure shows the integral of enthalpy with time plotted against the molar ratio of Phd 
and Oln2A. 
 
There have been also some oligonucleotides that did not exhibit measurable binding with 
Phd at all. An example of such a reaction is shown in Figure 19 below. It shows the 
titration curves of the Phd into Oln1A/T experiment. As there is no measurable interaction 
between the molecules, all the shown peaks in the upper part of the Figure 19 are due to 
the heat of dilution of Phd in the Oln1A/T sample solution. Due to no observable peaks, 
there is also no fitted sigmoid curve in the lover part of Figure 19, as there is no data to fit. 
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Figure 19: Titration of Phd into Oln1A. The top graph shows the raw ITC titration data and the bottom 
part of the figure shows the integral of enthalpy with time plotted against the molar ratio of Phd and 
OlnG1A.  
 
4.4.1 Binding of Phd to the wild type operator OlnG 
Phd binds to the wild type operator OlnG with nanomolar affinity. This binding is both 
enthalpically and entropically favourable (ΔH -2.8 kCal/mol and TΔS 6.8 kCal/mol). Since 
the enthalpy change (ΔH) of the reaction is negative, the enthalpy of the products is lower 
than that of the reactants, thus the reaction is exothermal. This can also be easily seen in 
Figure 17, where the peaks of the titration are turned downward. This signifies that heat 
was released into the experimental cell and less power had to be supplied to the cell jacket. 
The positive entropy change (ΔS) tells us that the reaction is, in contrast to most 
association reactions, also entropically favoured. The reason for this is difficult to explain 
but may be related to the behaviour of the IDR of the protein.  
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The N value in the Table III tells us about the stoichiometry of the Phd-OlnG binding 
reaction. This value can only be a whole number, so we must round the obtained value of 
0.9 up to the value of 1. From this we learn that one dimer of Phd binds one duplex of 
OlnG. This is in agreement with previous binding data (29; 24) and with the crystal 
structure of Phd in complex with a similar operator fragment (24). Ideally the N value 
should be precisely 1 in a perfect experiment.  
There are multiple possible reasons for the deviation of the measured N value. The ITC 
apparatus can only determine the N value accurately if all of the molecules in the solutions 
are in their working conformation. It is possible that some of the oligonucleotides were not 
annealed correctly, thus some one-stranded oligonucleotides were present in the solution 
which were not able to bind with Phd. It is also possible that some of the Phd molecules 
were degraded and could not bind the oligonucleotides. Finally, the concentrations that 
were determined for the solutions of the oligonucleotide and protein contained errors. 
Indeed, protein concentrations were determined from measuring the OD at 280 nm. The 
extinction coefficient was calculated theoretically from the amino acid sequence and 
therefore does not take into account the effects of (folded) environment on tyrosine, 
tryptophan and phenylalanine absorption, leading to possible systematic errors. 
To understand the origin of the binding energetics at the atomic level and to meaningfully 
compare binding of Phd to wild-type and mutant OlnG sequences, it is necessary to take a 
closer look at the interactions between the DNA bases and Phd amino acid residues in the 
binding region as seen in the corresponding crystal structure of Phd with a similar DNA 
fragment (24). 
The amino acid residues shown in Figure 20 below as well as the following paragraphs are 
labelled and referred to according to their position in the Phd sequence obtained from the 
PDB accession number 4zm0. The oligonucleotides are labelled and referred to according 
to their position in the OlnG palindromic sequence. The first oligonucleotide of the Phd 
binding 5-GTGTACAC-3 DNA sequence is named G15', the second T25', the third G35' and 
so on. 
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Figure 20: A representation of bonds formed between the α1 helix of a Phd monomer and one repeat of 
the GTGT sequence in the OlnG binding box. The amino acid residues are shown as orange sticks and 
labelled according to their position in the protein sequence. The bound DNA bases of both forward and 
reverse strands are shown as dark blue and light blue sticks respectively and labelled according to their 
position in the OlnG binding box. The numbers in superscript next to the DNA base names indicate on 
which strand of DNA they are found (5' to 3' or 3' to 5'). Van der Waals bonds are shown as yellow 
dashed lines, while hydrogen bonds are shown as green dashed lines (PDB ID: 4zm0). 
 
The most extensive contacts between these two molecules are established by the amino 
acid residues phenylalanine 6, arginine 7, arginine 10 and glycine 11, which are all part of 
the α1 α-helix in the head region of Phd and are shown in Figure 20 (24). Phenylalanine 6 
contacts to the methyl group of thymine 23' and the ribose of guanine 13' through van der 
Waals interactions. Its main chain NH group also contacts the phosphate backbone of 
guanine 13' via a hydrogen bond. The side chain of arginine 7 forms a hydrogen bond with 
guanine 13', while the side chain of arginine 10 forms a hydrogen bond to guanine 33'. The 
last amino acid from the α1 helix to contact the DNA is glycine 11 which establishes a van 
der Waals bond to thymine 45' via its methyl group on the C6 atom.  
Apart from the α1 helix the other structural elements that contribute to the binding are the 
α2 helix and the β-hairpin wing which extends to the sides of the Phd molecule. Of the α2 
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helix only serine 14 binds with DNA by bonding with the ribose of thymine 23'. The β-
hairpin wing contains the residues arginine 30, arginine 31, and arginine 33 which bond 
with DNA. Arginine 30 and arginine 33 both bind to the phosphate between guanine 13' 
and thymine 23'. Arginine 31 on the other hand binds with a thymine which is outside of 
the Phd binding box and thus has no effect on our experiment (24). 
The investigated oligonucleotide mutants differ only in the nucleotides but not in the 
backbone region of the DNA molecule. Therefore, the bonds to the ribose or phosphate 
backbone remain the same in the mutated oligonucleotides as they are in the wtOlnG. 
Thus, only the bonds of the amino acid residues arginine 7, phenylalanine 6, arginine 10 
and glycine 11 of the Phd dimers need to be investigated closely. 
 
4.4.2 Mutations at positions 1 and 8 of the OlnG palindrome 
Palindromic positions 1 and 8 contain a G/C and C/G pair respectively, which were 
simultaneously substituted to A/T, and G/C. The oxygen on carbon 6 of G1 and G8 forms a 
hydrogen bond with the side chain of arginine 7 of Phd. When guanine is substituted for 
adenine, this carbonyl group is replaced by an amino group, leading to a steric clash. This 
directly explains the inability of DNA variant Oln1A/T to bind to Phd (Table III). These 
results are in accordance with previously published findings by Zhao and Magnuson (38), 
where they investigated the specificity determinants of the Salmonella and P1 
bacteriophage addiction operons. They found that the seventh amino acid in the Phd 
sequence (arginine 7) and the first and last nucleotide pairs (G/C and C/G respectively) in 
the OlnG sequence are vital for the successful binding of Phd to OlnG. Their results 
indicated that any changes to the first or last nucleotide pair prevent the Phd molecule to 
bind with OlnG. 
In the Oln1G/C variant, a G/C pair is inverted to C/G, which effectively removes the 
hydrogen bond partner for arginine 7. This can explain the 20-times lower affinity for 
Oln1G/C. The difference in affinity of Oln1G/C is essentially due to a smaller enthalpic 
contribution (-0.4 kCal/mol instead of -2.8 kCal/mol for the wild-type sequence), which 
agrees well with what is expected for the removal of a single hydrogen bond (39). The 
entropy contribution is not affected, which may indicate that there is no significant 
influence on the structure or dynamics of neighbouring water layer. 
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4.4.3 Mutations at positions 2 and 7 of the OlnG palindrome  
The second and seventh position on the wtOlnG palindrome are occupied by T/A and A/T 
nucleotide pairs respectively. In the investigated mutants they were mutated to A/T and 
G/C nucleotide pairs. Mutations of these positions in wtOlnG seem to be less critical 
compared to mutations on positions 1 and 8. Interestingly, the mutant Oln2G/C retains its 
ability to bind with Phd, even though it replaces the position 2 thymine with a guanine. 
This is probably due to the fact that the position 2 thymine binds with phenylalanine 6 of 
Phd through a van der Waals bond. This bond is less specific than a hydrogen bond, thus it 
can be formed even though a less favourable DNA base replaces the wild type thymine. 
Van der Waals bonds are also weaker than hydrogen bonds, therefore they contribute less 
to the enthalpy of binding and have a lesser effect when one bond is removed. This is why 
even if the mutated oligonucleotide is unable to establish the Van der Waals bond with 
Phd, it is still possible for the two molecules to form a complex. Regardless, both of the 
mutations adversely affect the ability of Phd to bind to the mutant OlnG dimers.  
The Oln2A/T mutant which substitutes the position 7 adenine for a thymine (position 2 is 
already a thymine in wtOlnG) has much more favourable thermodynamics of binding than 
all of the other tested mutants. Its Kd decreased only 4-fold and its ΔH, TΔS and ΔG values 
are closer to the wild type OlnG than the rest of the tested mutants. This is probably due to 
its close similarity with the wtOlnG oligonucleotide. 
The second mutant tested in this group is Oln2G/C in which the second and seventh bases 
are substituted with a G/C pair. In accordance with our expectations, this mutant binds with 
the protein. The binding affinity with Phd is almost on par with Oln2A/T, its ΔH is less 
negative which indicates a more endothermal reaction than Oln2A/T.  
 
4.4.4  Mutations at positions 3 and 6 of the OlnG palindrome 
Similarly to the first and eighth position in the wtOlnG palindrome, the third and sixth 
position are composed of a G/C and C/G oligonucleotide pair, and the third guanine binds 
with an arginine molecule sidechain (arginine 10) with a hydrogen bond. Therefore, one 
can assume that the mutations on positions 3 and 6 will have a similar outcome as on the 
positions 1 and 8.  
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Oln2A/T, the mutant oligonucleotide that substitutes the guanine on position 3 for adenine 
and thymine, exhibits no measurable binding. Again, this can be attributed to a steric clash 
because of the substitution of the guanine carbonyl group for an amino group on the 
adenine molecule. Because of this substitution, the arginine 10 sidechain cannot form a 
hydrogen bond as it does in the wild type OlnG. 
The oligonucleotide Oln3G/C exhibits binding ability with Phd, which is similar to the 
position 1 and 8 mutants. The position 3 guanine and position 6 cytosine are mutated to 
cytosine in this case. Its affinity for Phd is reduced almost 10-fold compared to that of wild 
type OlnG. It also exhibits a positive change in enthalpy (0.9 kCal/mol). This signifies, that 
the enthalpy of the Phd/DNA complex is higher than of the unbound molecules in the 
solution. Therefore, heat was taken up during the binding process, making this an 
endothermal reaction by which it differs from the previously observed reactions.  
In this case the importance of hydrogen bonds can be seen again, as the Oln3A/T mutant 
can't form a hydrogen bond and is unable to bind with Phd. By comparing the binding 
affinities of Oln3G/C and Oln1G/C it can be seen that Oln3G/C binds with Phd more 
strongly. This shows that while being important, the conservation of the position 3 guanine 
in the palindromic sequence is still not as crucial as that of the position 1 guanine. 
 
4.4.5 Mutations at positions 4 and 5 of the OlnG palindrome 
The fourth and fifth positions in the OlnG palindrome are occupied by T/A and A/T pairs 
respectively. As with the other tested oligonucleotides, the mutants in this group exhibited 
weaker binding with Phd. In this group of mutants, results similar to the position 2 and 7 
mutants can be expected. 
In wtOlnG the thymine 4 of the reverse 3' DNA strand binds with glycine 11 of Phd with a 
van der Waals bond. This bond is established through the methyl group on the C6 atom of 
thymine 4.  
The first mutant, Oln4A/T, has the lowest measured affinity of all the mutated 
oligonucleotides, it is 220 times lower than that of wtOlnG. Possibly this is a fluke of the 
software used, as this data point is an extreme outlier and does not seem very probable. 
This mutant also exhibits a positive ΔH value, which is very high, at 3.0 kCal/mol, making 
this the most endothermic reaction we measured. It also has the highest entropy value at 
9.4 kCal/mol and highest ΔG at -6.4 kCal/mol making this the »worst« oligonucleotide 
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with a measurable interaction. Possibly a more accurate measurement result could have 
been obtained by using a higher concentration of protein in the sample cell. All in all, this 
mutant does not behave exactly as it was expected. By comparison the Oln2A/T mutant 
has much more favourable binding properties. Another possibility is that the Oln4A/T 
oligonucleotide is not annealed properly which hinders it's binding with Phd. While 
possible, this is very unlikely, as all of the oligonucleotides were annealed in the same 
apparatus concurrently and none other oligonucleotides exhibit this behaviour. 
The second oligonucleotide – Oln4G/C – exhibits binding, but it also has a positive ΔH 
value and the third highest affinity value of all the measured oligonucleotides. What is 
interesting is that it appears to have more favourable thermodynamics of binding than 
Oln4A/T while completely removing the methyl group of thymine that is necessary for the 
formation of the van der Waals bond. As previously discussed, the Van der Waals bond is 
weaker and contributes less to the overall binding strength of the DNA-protein complex 
than the hydrogen bond, so the absence of one Van der Waals bond does not necessarily 
prevent binding. 
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5 CONCLUSIONS 
The aim of this thesis was to study the structure-function relationship of Phd, an antitoxin 
and transcription regulator from the bacteriophage P1 phd/doc toxin-antitoxin system. Phd 
and Doc were co-expressed in E. coli and the resulting Phd/Doc complex was retained on a 
Ni-NTA affinity column via the C-terminal his-tag on Doc. Phd was subsequently isolated 
via an on-column unfolding/refolding protocol followed by size exclusion 
chromatography. The hypothesis that the stability and secondary structure content of Phd 
heavily depend on ionic strength was investigated. CD spectroscopy measurements did not 
show noticeable differences in secondary structure composition between buffers with 
increasing ionic strength. However, the structural integrity of the isolated Phd was 
confirmed, as the shape of the CD spectra curves is in agreement with an α-helix 
dominated secondary structure. 
The thermal stability of Phd was evaluated in a large array of differing buffers in order to 
evaluate the effect of ionic strength and to determine which buffer provides the best 
environment for ITC experiments with DNA ligands. The chosen method for this (thermal 
shift assay) proved to be suboptimal and the results are not fully conclusive. Possibly the 
SYPRO orange dye used in this experiment binds with the intrinsically disordered tail 
region of Phd even at low temperatures, at which the protein is otherwise still stable. This 
results in a high initial flourescence reading and skews the measurements obtained at 
higher temperatures, at which the protein denatures. As no buffer in particular stood out, a 
buffer which has already been used previously for ITC titrations with Phd was used in 
further experiments aimed at characterizing its structural basis of DNA specificity. 
The affinity and thermodynamic parameters obtained by isothermal titration calorimetry 
for the wild-type operator sequence are in agreement with previously published data. Most 
of the investigated mutants of the operator sequence showed binding with Phd, however, 
all of them performing significantly worse than the wild-type OlnG operator sequence. The 
formation of the DNA-protein complex is largely dependent on the formation of hydrogen 
and Van der Waals bonds. All of the mutants that bound with Phd have retained the ability 
to form hydrogen bonds with the protein, while some lost the ability to form Van der 
Waals bonds.  
Two operator mutants showed no measurable binding. Both have a nucleotide substituted 
that is necessary for the formation of a hydrogen bond with Phd. This shows the 
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importance of hydrogen bonds in the formation of DNA-protein complexes. While Van der 
Waals bonds are also an important factor in the formation of these complexes, they usually 
influence the strength of the binding by their sheer number, not the strength of a single 
bond. In this case, the number of hydrogen bonds involved in the creation of the complex 
is the same as the number of Van der Waals bonds. Therefore, the removal of a single 
hydrogen bond has a much larger influence than the removal of a Van der Waals bond. 
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